Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Emily D. Clark, DO
Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
Susan Scanland, MSN, CRNP, GNP-BC, CDP
Anthony J. Viera, MD, MPH
New Pathways in the Treatment of DMD
Erika Finanger, MD, MS
Aravindhan Veerapandiyan, MD
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Stephen Chrzanowski, MD, PhD
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD
Jonathan M. Meyer
Treatment of a Broader Population of Patients With DMD
Crystal Proud, MD
Establishing Our Foundation of LGMD2I/R9: Unlocking the Genetics
Conrad Weihl, MD, PhD
Optimizing Patient Management Strategies
John Vissing, MD, DMSci
The Role of Multidisciplinary Care in LGMD2I/R9
Advancing Care: Clinical Innovations on the Horizon
Recognizing Early Signs of LGMD2I/R9
Establishing Our Foundation of LGMD2I/R9
New Frontiers in the Treatment of DMD Across the Age Spectrum
John Brandsema, MD
Omer Abdul Hamid, MD
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
James R. Bateman, MD, MPH
B. Joy Snider, MD, PhD
Jerome A. Barakos, MD
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Charles P. Vega, MD
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.